NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.
about
Galactomannan detection for invasive aspergillosis in immunocompromized patientsCurrent and emerging azole antifungal agentsSystemic availability of itraconazole in lung transplantationHow to manage aspergillosis in non-neutropenic intensive care unit patientsTreatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialIn vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agentsEfficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosisIn vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeastsAspergillus fumigatus and aspergillosis2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.History of medical mycology in the united states.Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry.Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.Antifungal and antiviral agents: a review.Itraconazole in cyclodextrin solution.Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.Protists as opportunistic pathogens: public health impact in the 1990s and beyond.Treatment of fungal infections in surgical patients using conventional antifungals.Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Voriconazole: a new triazole antifungal.Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centreIn vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogensItraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole.Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.Itraconazole.Intravenous itraconazole.Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies.Treatment options in Invasive Aspergillosis.Antifungal clinical trials and guidelines: what we know and do not knowDoes hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?Review of the safety and efficacy of voriconazole.Clinical hepatotoxicity associated with antifungal agents.Treatment of documented and suspected neutropenia-associated invasive fungal infections.Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?Caspofungin acetate for treatment of invasive fungal infections.Itraconazole--perspectives for the management of invasive aspergillosis.Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature.
P2860
Q24240734-E23FDAAD-9577-4B6C-B92A-59C66A879CBDQ24550733-F85BF171-CE74-4452-9BE5-E47BF4126BCEQ24675285-9916946E-47E6-4950-8AF1-8EB85F306B21Q26999448-EF4ECCB0-0505-48C6-B36F-865286D39441Q28277029-2A49A8E5-060F-45A5-B711-9F78819AF9C9Q28345946-01974FB6-CBA9-430C-B6C6-6308E80375F0Q28379262-D336A55F-599D-46FF-B567-4D41DAD9A36FQ28379385-E8122E4C-1B7A-45A7-B6F7-7E630EE224C9Q29617908-E9732328-87FE-4D86-8F4C-E7F440944185Q30151881-67BFB26D-9651-4710-A05F-83C6AE26B031Q30452877-7D12D098-DD06-4C7E-9766-11F0DF0AC163Q33371455-4F542276-ED0F-4FA7-91A8-0448EE5E6029Q33503546-C4D645E9-682C-4C75-BECA-DDC32F5E75CEQ33539956-F5408CEE-6019-40B8-9283-C22FAD1501F5Q33637258-E4413C35-ABD9-45E7-9555-E5A246AE0AE2Q33689568-C679C49D-7496-4A6F-8F42-FBBC0E387F57Q33690036-EC57B1F7-EAEA-4F5E-9F6D-73191803C7CCQ33826129-30BF3455-02DE-40D9-867B-660E8B6495BEQ33840086-A1307925-F2E8-42AB-9CB9-BB59F766C1DAQ33894472-16084566-24E9-4D96-A0C9-7A7EC07E7AA2Q33917339-5B4D9FAC-A739-4FD6-AF64-D7FD6AE45E8DQ33964833-58ADEA8F-E300-4789-9835-27D31596B9CDQ33976817-0B6EEE4C-7BD9-48AF-B8F0-B708BE36D335Q33980029-5FF3F527-2A67-4054-8CF2-448C5D856465Q33981488-8AEEEC02-EC6D-462B-ACD6-2378F6E3C430Q34069443-A5AB978B-9CDF-4C84-B01D-86570D40BCB0Q34182267-A4908B23-CC07-4DDD-A96F-5BB8C332204AQ34284268-EC2706A5-2C82-42D5-8FF0-55CF576DC35DQ34330077-4669A286-7D8F-4F1C-90D7-B66F58646D73Q34357504-819F9EDE-AED9-4E35-BF27-4FAACDC79EAAQ34400255-C8DBF562-BA45-44C4-B46E-3CFBDEA8DFEBQ34475708-BDD1B768-27B7-4665-82A4-EC1A7264586FQ34544679-62C3685A-0FF1-4915-A92A-29EC9492D082Q34546811-B93B97D4-AADC-4688-ADBB-04AB7DCB7614Q34590013-B8486078-2C77-4798-9043-46175A7CA06DQ34768471-F92F4BA1-2370-430A-87B6-3511BCF852B0Q35022494-204C1A9D-2A7A-45B3-A4E6-FD977AA6BE1DQ35035091-17262D5B-3907-4C59-BAB6-299669F84BDDQ35105394-348D314A-8804-4711-9F83-6C70CBD022ACQ35121425-94254980-8C1E-4702-BDEE-42079EA0EA22
P2860
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@en
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@nl
type
label
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@en
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@nl
prefLabel
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@en
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@nl
P2093
P1476
NIAID Mycoses Study Group Mult ...... py for Invasive Aspergillosis.
@en
P2093
A Catanzaro
C A Kauffman
D H Dewsnup
J N Galgiani
J R Graybill
J S Hostetler
P304
P356
10.1016/0002-9343(94)90023-X
P407
P577
1994-08-01T00:00:00Z